Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors Grant US-11866432-B2 United States of America 09 Jan 2024
Single-dose, ready-to-use injectable formulations Grant US-11819499-B2 United States of America 21 Nov 2023
Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors Grant US-11780823-B2 United States of America 10 Oct 2023
Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof Grant US-11697649-B2 United States of America 11 Jul 2023
Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway… Grant US-11684615-B2 United States of America 27 Jun 2023
2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof Grant US-11667632-B2 United States of America 06 Jun 2023
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors Grant US-11472791-B2 United States of America 18 Oct 2022
Tricyclic amine compounds as CDK2 inhibitors Grant US-11447494-B2 United States of America 20 Sep 2022
Single-dose, ready-to-use injectable formulations Grant US-11446288-B2 United States of America 20 Sep 2022
Tricyclic amine compounds as CDK2 inhibitors Grant US-11440914-B2 United States of America 13 Sep 2022
Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors Grant US-11427567-B2 United States of America 30 Aug 2022
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2… Grant US-11384083-B2 United States of America 12 Jul 2022
COMPOUNDS FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEOSOME PATHWAY Application WO-2022140472-A1 World Intellectual Property Organisation (WIPO) 30 Jun 2022
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors Grant US-11066404-B2 United States of America 20 Jul 2021
BIOMARKERS FOR PROGNOSIS OF LUNG CANCER Application WO-2014072086-A1 World Intellectual Property Organisation (WIPO) 15 May 2014